September 2026 - Page 13 of 16

FridaySep 04, 2026 9:00 am

From Molecule to Medicine: Onco-Innovations Aligns ONC010 for Clinical Development

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations has advanced ONC010 across API manufacturing, polymer optimization, analytical development, preclinical characterization and clinical planning as it works toward human evaluation. A 300-gram development batch of ONC010's active ingredient achieved approximately 99.3% purity, while a newly identified non-tin catalyst could support improved control of impurities in future polymer manufacturing. The company is building an Australian pathway for a potential First-in-Human study while advancing bioanalytical, metabolism, ADME, toxicology, biodistribution and regulatory preparation during the second half of 2026. Cancer therapies built around…

FridaySep 04, 2026 9:00 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer

VERAXA Biotech (NASDAQ: VRXA) a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management and strategic leadership. He will report to CEO and Co-Founder Christoph Antz, Ph.D., and is expected to support the company’s capital strategy, strategic opportunities and continued development of its proprietary BiTAC(R) technology platform and oncology pipeline. Prior to joining VERAXA, Willener served as director of corporate development at Exentis Group AG before being appointed CFO in…

ThursdaySep 03, 2026 1:35 pm

QualityStocksNewsBreaks – MindWave Innovations Inc.’s (NYSE American: APUS) NILA Gains US Access Ahead of MindChain Launch

MindWave Innovations (NYSE American: APUS) is positioning itself at the intersection of institutional Bitcoin treasury management and blockchain infrastructure, developing tools designed to help corporations and institutions hold, manage and potentially generate risk-aware yield from Bitcoin reserves while incorporating traditional financial controls with blockchain efficiency. Through its broader MindWaveDAO ecosystem, the company is combining treasury services with AI-enabled yield capabilities, staking, governance, tokenization and blockchain technology, with its native $NILA token now available to eligible U.S. users through Webot. The company’s next major milestone is the planned October 2026 launch of MindChain, an independent, EVM-compatible Layer 2 that MindWave says will…

ThursdaySep 03, 2026 12:51 pm

QualityStocksNewsBreaks – AZIO AI Holdings Inc. (NASDAQ: AZIO) Positions to Meet Rising Infrastructure Demand

AZIO AI Holdings (NASDAQ: AZIO) is an emerging technology company focused on developing AI data centers, GPU and high-performance computing, digital power and related infrastructure. The company was featured in a recent article that discussed its efforts to advance a planned Texas campus with up to 500 megawatts of power capacity and key developments. These include a reported $27.9 million AI infrastructure and capacity agreement with Power Champion Investment Limited, potentially scalable to $100 million, and a roughly $2.4 million Master Services Agreement with AT&T for high-capacity fiber connectivity. The company is also pursuing GPU and server sales, power hosting, compute…

ThursdaySep 03, 2026 12:20 pm

QualityStocksNewsBreaks – OS Therapies Inc. (NYSE American: OSTX) Heads to Moody Capital Conference Amid Major OST-HER2 Regulatory Push

OS Therapies (NYSE American: OSTX) announced its upcoming participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9-10 in New York City, where OS Animal Health will participate and the company is expected to engage with investors and strategic partners. The conference comes as OS Therapies enters a potentially significant regulatory period for OST-HER2, its investigational therapy for fully resected pulmonary metastatic osteosarcoma. The company expects interim three-year overall survival data and key FDA and U.K. regulatory meetings in September, followed by potential RMAT and Rolling Review decisions, with final three-year data, a U.S.…

ThursdaySep 03, 2026 11:10 am

QualityStocksNewsBreaks – Frontieras North America Confidentially Submits Draft Registration Statement for Proposed IPO

Frontieras North America announced that it confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for a proposed initial public offering of its common stock. The number of shares and proposed price range have not yet been determined, and the offering remains subject to completion of the SEC review process, market conditions and other conditions. To view the full press release, visit https://ibn.fm/NhCOX About Frontieras North America Frontieras North America is an energy and environmental technology company commercializing FASForm, a patented Solid Carbon Fractionation process that transforms coal and other hydrocarbons into clean-burning fuels, hydrogen, industrial carbon, and agricultural products. The company is focused on delivering abundant, affordable, and available…

ThursdaySep 03, 2026 10:54 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Expands AI-Powered Robotics Platform Across Multiple Industries

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, provided an update on initiatives expanding its AI-powered enterprise automation platform beyond hospitality into pharmaceutical, semiconductor, industrial and connected robotic operations. Recent developments include a strategic supply and development agreement with Taiwan-based JJ Enterprise, Phase 2 deployment of its PUR-E autonomous support robot at SAPU Bio, development of its proprietary Robotic Connective Network and a nonbinding LOI with NBR Intelligence targeting potential deployment of up to 5,000 robotic systems. The company also established an independent board majority and three standing committees, appointed Yury Pyatigorsky as CFO and formed a six-member Industry Advisory Board. Nightfood said it plans to advance these commercial and technology…

ThursdaySep 03, 2026 10:30 am

HWAL Inc. (HWAL) Pioneers Tokenized Approach to Music Royalties

The tokenized real-world asset market reached an estimated $60 billion in value across more than 7,000 products by mid-2026. In January 2026, Lunar Records, of which HWAL owns 50% through its subsidiary Melody Trust LLC, formed Lunar Records Fund 1, the first tokenized real-world asset fund built around music royalties. For decades, musicians and songwriters have complained that royalty statements arrive late, are hard to audit and rarely show from whence the money came. HWAL (OTC: HWAL) is taking an innovative approach to that problem using tokenized assets. The broader trend HWAL is riding is real and growing quickly. The tokenized real-world…

ThursdaySep 03, 2026 10:26 am

QualityStocksNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Highlights Sarfartoq Closing and Skaergaard Development Progress

Greenland Mines (NASDAQ: GRML) issued a shareholder letter from President Dr. Bo Møller Stensgaard highlighting progress since the company rebranded in March, including the Sept. 1 closing of its Sarfartoq Neodymium-Praseodymium Rare Earths Project acquisition and ongoing development work at the Skaergaard palladium-gold-platinum project. At Sarfartoq, the company cited an independent Initial Assessment with a high-case pre-tax NPV of approximately $2.05 billion and 118.6% IRR including Indicated and Inferred Mineral Resources, alongside an updated estimate of 6.9 million tonnes of Indicated resources at 1.60% TREO and 5.3 million tonnes of Inferred resources at 0.96% TREO. Greenland Mines also highlighted Neo Performance Materials as a strategic shareholder with offtake rights for up to…

ThursdaySep 03, 2026 9:45 am

Frontieras North America Inc.’s Leaders Bring Core Expertise, Background as Company Moves Toward Commercial Execution

For companies seeking to lead the way forward in industrial technology, leadership experience can become a strategic asset equal in importance to the underlying technology itself. Cofounder, CEO and chair Matthew McKean’s professional background spans sales, management, finance and entrepreneurship. Cofounder and CTO Joseph Witherspoon’s career has been centered on engineering, process design and industrial project execution. The success of large-scale industrial and energy technologies often depends on more than the technology itself. Companies must also possess the leadership, operational expertise and execution capabilities necessary to move projects from development into commercial operation. Frontieras North America is pursuing that path…

Site Search

Company Search

Month: September 2026